XTL Biopharmaceuticals Ltd.

XTLB

$1.66

Name : XTL Biopharmaceuticals Ltd.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $4,079,388.00

EPSttm : -0.36

XTL Biopharmaceuticals Ltd.

$1.66

0.00%

$0.00000000000000

XTLB — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.1

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

1.62

Target Price

Analyst Recom

Performance Q

-44.64

Upside

N/A

Beta

1.49

Ticker: XTLB

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	XTLB	1.98	N/A	N/A	0
2026-10-14	XTLB	1.88	N/A	N/A	0
2026-10-15	XTLB	1.99	N/A	N/A	0
2026-10-16	XTLB	1.94	N/A	N/A	0
2026-10-19	XTLB	1.96	N/A	N/A	0
2026-10-20	XTLB	1.9599	N/A	N/A	0
2026-10-21	XTLB	1.86	N/A	N/A	0
2026-10-22	XTLB	1.78	N/A	N/A	0
2026-10-23	XTLB	1.82	N/A	N/A	0
2026-10-26	XTLB	1.89	N/A	N/A	0
2026-10-27	XTLB	1.81	N/A	N/A	0
2026-10-28	XTLB	1.89	N/A	N/A	0
2026-10-29	XTLB	1.82	N/A	N/A	0
2026-10-30	XTLB	1.61	N/A	N/A	0
2026-11-02	XTLB	1.7001	N/A	N/A	0
2026-11-03	XTLB	1.73	N/A	N/A	0
2026-11-04	XTLB	1.705	N/A	N/A	0
2026-11-05	XTLB	1.71	N/A	N/A	0
2026-11-06	XTLB	1.6	N/A	N/A	0
2026-11-09	XTLB	1.63	N/A	N/A	0
2026-11-10	XTLB	1.78	N/A	N/A	0
2026-11-11	XTLB	1.66	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	XTLB	1.92	-	-	-
2026-10-14	XTLB	1.87	-	-	-
2026-10-15	XTLB	1.95	-	-	-
2026-10-16	XTLB	2.00	-	-	-
2026-10-19	XTLB	1.83	-	-	-
2026-10-20	XTLB	1.83	-	-	-
2026-10-21	XTLB	1.93	-	-	-
2026-10-22	XTLB	1.91	-	-	-
2026-10-23	XTLB	1.82	-	-	-
2026-10-26	XTLB	1.78	-	-	-
2026-10-27	XTLB	1.80	-	-	-
2026-10-28	XTLB	1.89	-	-	-
2026-10-29	XTLB	1.77	-	-	-
2026-10-30	XTLB	1.61	-	-	-
2026-11-02	XTLB	1.87	-	-	-
2026-11-03	XTLB	1.67	-	-	-
2026-11-04	XTLB	1.73	-	-	-
2026-11-05	XTLB	1.63	-	-	-
2026-11-06	XTLB	1.55	-	-	-
2026-11-09	XTLB	1.56	-	-	-
2026-11-10	XTLB	1.78	-	-	-
2026-11-11	XTLB	1.62	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	XTLB	0.00	-99.81	0.15
2026-10-14	XTLB	0.00	-99.81	0.15
2026-10-15	XTLB	0.00	-99.81	0.15
2026-10-16	XTLB	0.00	-99.81	0.15
2026-10-19	XTLB	0.00	-99.78	0.15
2026-10-20	XTLB	0.00	-99.78	0.15
2026-10-21	XTLB	0.00	-99.78	0.15
2026-10-22	XTLB	0.00	-99.78	0.15
2026-10-23	XTLB	0.00	-99.78	0.15
2026-10-26	XTLB	0.00	-99.78	0.15
2026-10-27	XTLB	0.00	-99.78	0.10
2026-10-28	XTLB	0.00	-99.78	0.10
2026-10-29	XTLB	0.00	-99.78	0.10
2026-10-30	XTLB	0.00	-99.78	0.10
2026-11-02	XTLB	0.00	-99.75	0.10
2026-11-03	XTLB	0.00	-99.75	0.10
2026-11-05	XTLB	0.00	-99.75	0.10
2026-11-06	XTLB	0.00	-99.75	0.10
2026-11-09	XTLB	0.00	-99.73	0
2026-11-10	XTLB	0.00	-99.73	0.10
2026-11-11	XTLB	0.00	-99.73	0.10
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-99.73

Beta

1.49

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

91.9

Max Drawdown 5-Year %

-89.5

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.64

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ XTLB Healthcare

$1.55

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

20/25

Volume

9/15

Valuation

12/20

TP/AR

2/10

Options

0/10

RSI

37.8

Range 1M

24.1%

Sup Dist

1.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

8/30

Estimates

0/20

Inst/Vol

0/15

Options

0/10

EPS Yr

EPS NY

52W%

3.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +287.1% upside

Quality

2/30

Valuation

16/30

Growth

3/25

Stability

4/10

LT Trend

1/5

Upside

+287.1%

Quality

XTLB — P/E HistoricalBiotechnology

XTL Biopharmaceuticals Ltd.

Sector: Healthcare

Industry: Biotechnology

Employees: 4

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. The company's lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Herzliya, Israel.

XTLB

Latest News

—

Caricamento notizie per XTLB…

stock quote shares XTLB – X.T.L. Biopharmaceuticals Ltd. ADR Stock Price stock today

news today XTLB – X.T.L. Biopharmaceuticals Ltd. ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch XTLB – X.T.L. Biopharmaceuticals Ltd. ADR yahoo finance google finance

stock history XTLB – X.T.L. Biopharmaceuticals Ltd. ADR invest stock market

stock prices XTLB premarket after hours

ticker XTLB fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: XTLB

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y